KIR down-regulation on NK cells is associated with down-regulation of activating receptors and NK cell inactivation (Q40802002)

23 September 2017

title

KIR down-regulation on NK cells is associated with down-regulation of activating receptors and NK cell inactivation (English)

1 reference

23 September 2017

Huard B

1

1 reference

23 September 2017

Karlsson L

series ordinal

2

1 reference

23 September 2017

Triebel F

series ordinal

3

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

European Journal of Immunology

23 September 2017

published in

1 reference

23 September 2017

volume

31

1 reference

23 September 2017

issue

6

1 reference

23 September 2017

page(s)

1728-1735

1 reference

Natural killer cells: from no receptors to too many

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

HLA class I specific inhibitory receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Human NK cells: their ligands, receptors and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Early signaling via inhibitory and activating NK receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

KIR expression on self-reactive CD8+ T cells is controlled by T-cell receptor engagement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Target-induced anergy of natural killer cytotoxic function is restricted to the NK-target conjugate subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Activating interactions in human NK cell recognition: the role of 2B4-CD48

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Inhibitory receptors alter natural killer cell interactions with target cells yet allow simultaneous killing of susceptible targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Natural history of HLA expression during tumour development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

CD3.TCR1, a human CD3 epitope expressed on viable gamma/delta lymphocytes exclusively

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

CD4/major histocompatibility complex class II interaction analyzed with CD4‐ and lymphocyte activation gene‐3 (LAG‐3)‐Ig fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 ζ chain, FcεRI γ chain and the p56lck kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200106%2931%3A6%3C1728%3A%3AAID-IMMU1728%3E3.0.CO%3B2-J

10.1002/1521-4141(200106)31:6<1728::AID-IMMU1728>3.0.CO;2-J

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference